{"id":"https://genegraph.clinicalgenome.org/r/1479f0e1-5d8e-486e-927c-fe30ce2b2b9fv1.1","type":"EvidenceStrengthAssertion","dc:description":"The SOX3 gene is located on the X chromosome at Xq27.1 and encodes a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. SOX3 was first reported in relation to *SOX3*-related X-linked pituitary hormone deficiency with or without intellectual developmental disorder in 2002 (Laumonnier et al., PMID: 12428212, MONDO:0800474). This X-linked inherited disease is characterized by growth hormone deficiency due to hypopituitarism and in some cases intellectual disability. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found a difference in molecular mechanism and phenotypic variability. Therefore, the following disease entities panhypopituitarism, X-linked (OMIM: 312000) and intellectual developmental disorder, X-linked, with isolated growth hormone deficiency (OMIM: 300123) have been lumped and are included in this curation. Whereas, 46,XX sex reversal 3 (MONDO:0010442), X-linked congenital generalized hypertrichosis (ORPHA:79495) and Septo-optic dysplasia spectrum (ORPHA:3157) have been split.\nAt least 7 variants including 2 missense, 1 frameshift, 4 in-frame polyA indels have been reported in 8 probands in 7 publications (PMIDs: 30125608, 29175558, 35295983, 21289259, 15800844, 19654509, 12428212) and are included in this curation. The mechanism of pathogenicity appears to be gain of function for polyA in-frame deletion variants and loss of function for polyA in-frame insertion variants.\nThis gene-disease association is also supported by expression and protein-protein interaction with HESX1 (PMID: 15800844), which is associated with pituitary hormone deficiency (PMID: 27000987). Also included is a conditional knockout mouse model which demonstrates lower levels of pituitary growth hormone, luteinizing hormone, follicle stimulating hormone and thyroid stimulating hormone (PMID: 14981518). \nIn summary, there is moderate evidence supporting the relationship between SOX3 and X-linked pituitary hormone deficiency with or without intellectual developmental disorder (MONDO:0800474).\nWhile more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date 08/02/23 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1479f0e1-5d8e-486e-927c-fe30ce2b2b9f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/796f4ae7-c817-44d4-935b-babf74a0ce47","calculatedEvidenceStrength":"Moderate","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/796f4ae7-c817-44d4-935b-babf74a0ce47_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2023-08-02T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/796f4ae7-c817-44d4-935b-babf74a0ce47_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-01-22T21:23:51.140Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/796f4ae7-c817-44d4-935b-babf74a0ce47_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/796f4ae7-c817-44d4-935b-babf74a0ce47_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3de281c2-6757-47b9-a92e-eb1ef5fa88c3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f1476d5-2fc2-490e-aa4f-7b2956408d1e","type":"Finding","dc:description":"GTEx","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32913098","rdfs:label":"GTEx expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/03f61aa2-270b-49a0-9d87-b4b454d054be","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94e80f86-d437-4b16-acd8-ce581a8cdcca","type":"Finding","dc:description":"Using a reporter construct of the firefly luciferase gene downstream of the proximal promoter of Hesx1, the luciferase assay showed that increasing amounts of wild-type SOX3 activated\nthe Hesx1 reporter up to 6-fold in a dose-dependent manner, whereas with the mutated SOX3 construct, the maximal activation achieved was 3-fold. Therefore, suggesting that expansion of the PA tract reduced the efficacy of SOX3.\nin this assay.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15800844","rdfs:label":"Luciferase assay","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/796f4ae7-c817-44d4-935b-babf74a0ce47_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/87d2da18-2ef9-4f2f-afd9-19469e93d129","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f5a071c-5f29-4b03-b22a-dc5da7740a9e","type":"Finding","dc:description":"The mice had abnormal pituitary function with lower levels of pituitary growth hormone, luteinizing hormone, follicle stimulating hormone and thyroid stimulating hormone. This resembles the human disease.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14981518","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/796f4ae7-c817-44d4-935b-babf74a0ce47_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63305054-1410-4a6d-8ac8-cb35dfd410d9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63305054-1410-4a6d-8ac8-cb35dfd410d9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21289259","allele":{"id":"https://genegraph.clinicalgenome.org/r/aa774144-8152-4335-8f33-c932ab82d65e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005634.3(SOX3):c.725_726insCGCCGCCGCCGCCGCCGCCGC (p.Ala242_Ala243insAlaAlaAlaAlaAlaAlaAla)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580618107"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}},{"id":"https://genegraph.clinicalgenome.org/r/63305054-1410-4a6d-8ac8-cb35dfd410d9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In the luciferase assay this variant resulted in reduced transcriptional activation compared to WT (PMID: 21289259, 17127446)\n\nThis variant has also been shown to cause impaired nuclear localization of SOX3 (PMID: 15800844)\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c645f03e-58f5-4873-a8b6-5a54a32cd34d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c645f03e-58f5-4873-a8b6-5a54a32cd34d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15800844","allele":{"id":"https://genegraph.clinicalgenome.org/r/aa774144-8152-4335-8f33-c932ab82d65e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c645f03e-58f5-4873-a8b6-5a54a32cd34d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This mutation led to reduced transcriptional activity, with impaired nuclear localization of the mutant protein. \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f1545ead-cccf-4135-afd0-836d7d442db2","type":"EvidenceLine","dc:description":"Expected to escaped NMD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1545ead-cccf-4135-afd0-836d7d442db2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35295983","allele":{"id":"https://genegraph.clinicalgenome.org/r/826d0353-86eb-4c46-96e9-c73d26166fad","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005634.3(SOX3):c.287del (p.Gly96AlafsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580618099"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6eceacbd-a943-4bcb-9776-fd798977453e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6eceacbd-a943-4bcb-9776-fd798977453e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30125608","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8860b88-a294-4436-883d-ea63e29a5ebd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005634.3(SOX3):c.424C>A (p.Pro142Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414478806"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}},{"id":"https://genegraph.clinicalgenome.org/r/6eceacbd-a943-4bcb-9776-fd798977453e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Utilizing transactivation assays of SOX3 with the HESX1 promoter reporter, the SOX3 p. P142T resulted in an up to 2.5-fold increase in transcriptional activation compared to SOX3 WT. \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/38356384-8ed5-4b32-bfbd-daae7b7c6112","type":"EvidenceLine","dc:description":"GCEP decision to give extra points for the family pedigree","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/38356384-8ed5-4b32-bfbd-daae7b7c6112_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29175558","allele":{"id":"https://genegraph.clinicalgenome.org/r/e538bdd8-30a6-412b-ad52-2f82994a4afb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005634.3(SOX3):c.449C>A (p.Ser150Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414478744"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/796f4ae7-c817-44d4-935b-babf74a0ce47_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e23a9e17-9587-4fa5-b029-cb4fa36ff50f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12428212","rdfs:label":"N3","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/e23a9e17-9587-4fa5-b029-cb4fa36ff50f","type":"Family","rdfs:label":"N3","member":{"id":"https://genegraph.clinicalgenome.org/r/5b56cfef-ced9-4929-a642-7ffd71388960","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12428212","rdfs:label":"IV-2","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc5e57fa-ab37-47ad-8cb3-cc677fffca27","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005634.3(SOX3):c.712_744dup (p.Ala248_Ser249insAlaAlaAlaAlaAlaAlaAlaAlaAlaAlaAla)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580101593"}},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0004322","obo:HP_0000824","obo:HP_0001249"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8778e8f1-40c2-4f42-b7ec-d2d5e74530b8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12428212","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc5e57fa-ab37-47ad-8cb3-cc677fffca27"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Facial anomalies in some members","phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0004322","obo:HP_0000824","obo:HP_0001249"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/5b56cfef-ced9-4929-a642-7ffd71388960"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e5c2473d-d225-4aef-a264-ea8435b49490_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29175558","rdfs:label":"Jelsig family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/e5c2473d-d225-4aef-a264-ea8435b49490","type":"Family","rdfs:label":"Jelsig family","member":{"id":"https://genegraph.clinicalgenome.org/r/61c760ea-2234-4360-9cb8-ce6774792862","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29175558","rdfs:label":"V-6","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e538bdd8-30a6-412b-ad52-2f82994a4afb"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Facial dysmorphology, microcephaly ","phenotypes":["obo:HP_0008245","obo:HP_0000164","obo:HP_0000568","obo:HP_0000589","obo:HP_0002342","obo:HP_0040075"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/38356384-8ed5-4b32-bfbd-daae7b7c6112_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Facial dysmorphology, microcephaly ","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0002342","obo:HP_0040075","obo:HP_0000164","obo:HP_0000568","obo:HP_0000589"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/61c760ea-2234-4360-9cb8-ce6774792862"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/2d7cdae8-dc13-4875-8083-2bd439b22701_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19654509","rdfs:label":"Burkitt Wright Family","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/2d7cdae8-dc13-4875-8083-2bd439b22701","type":"Family","rdfs:label":"Burkitt Wright Family","member":{"id":"https://genegraph.clinicalgenome.org/r/2dd3a75d-3cc5-4059-a19e-bba4efbda641","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19654509","rdfs:label":"III:4 ","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/aa774144-8152-4335-8f33-c932ab82d65e"},"firstTestingMethod":"PCR","phenotypeFreeText":"Isolated growth hormone deficiency","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/846996ab-c091-4164-bb52-d7b1a62d0f95_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19654509","allele":{"id":"https://genegraph.clinicalgenome.org/r/aa774144-8152-4335-8f33-c932ab82d65e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Isolated growth hormone deficiency","phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/2dd3a75d-3cc5-4059-a19e-bba4efbda641"},"publishedLodScore":2.68,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.7},{"id":"https://genegraph.clinicalgenome.org/r/846996ab-c091-4164-bb52-d7b1a62d0f95","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/846996ab-c091-4164-bb52-d7b1a62d0f95_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8778e8f1-40c2-4f42-b7ec-d2d5e74530b8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8778e8f1-40c2-4f42-b7ec-d2d5e74530b8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8778e8f1-40c2-4f42-b7ec-d2d5e74530b8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional evidence demonstrating decreased transactivation activity (labelled as SOX3^26Ala) In Wong et al 2007 (PMID: 17127446)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/844c6b1d-b031-4bbf-b215-c33a39a6d309","type":"EvidenceLine","dc:description":"High variant allele frequency, low REVEL score, and functional data does not support altered protein function.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/844c6b1d-b031-4bbf-b215-c33a39a6d309_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21289259","allele":{"id":"https://genegraph.clinicalgenome.org/r/92f9b555-0de5-4d75-ad46-5dcb2af116c1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005634.3(SOX3):c.14G>A (p.Arg5Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA200495"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":4.8}],"evidenceStrength":"Moderate","sequence":7717,"specifiedBy":"GeneValidityCriteria10","strengthScore":7.8,"subject":{"id":"https://genegraph.clinicalgenome.org/r/cuNIlpfduvc","type":"GeneValidityProposition","disease":"obo:MONDO_0800474","gene":"hgnc:11199","modeOfInheritance":"obo:HP_0001417"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_796f4ae7-c817-44d4-935b-babf74a0ce47-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}